On the one hand, although CD44-ICD itself lacks kinase activity, it can interact with cofactors and adaptor molecules to regulate actin-cytoskeleton network remodeling and various cellular signaling pathways, which subsequently enhance the invasive behavior of tumor cells (15). The gene discussed is CD44; the disease is neoplasm.